Business · 03/09/2019Updated: 10/17/2026 · 1 min read

FDA Extends Comment Period for Draft Guidance on Medical Devices and Magnetic Resonance Environment

The Food and Drug Administration (FDA) is extending the comment period for its draft guidance on testing and labeling medical devices for safety in the magnetic resonance environment, in response to a request from industry and FDA staff, until a later date to be announced.